Asimenia Angelidou | Neonatologist
Harvard Medical School

Dr. Angelidou is a Board-certified Neonatologist at Beth Israel Deaconess Medical Center (Boston, MA), Principal Investigator and Clinical Lead at the Precision Vaccines Program (PVP) in Boston Children’s Hospital, and Assistant Professor in Pediatrics at Harvard Medical School. She obtained her medical degree and doctoral degree in Immunopharmacology from the University of Athens in Greece. Dr. Angelidou completed clinical training in Pediatrics at the University of Texas Southwestern and Children’s Medical Center at Dallas, TX, and Neonatal-Perinatal Medicine at the Harvard Combined Training Program in Neonatology. Her research interests include neonatal immunology and infectious diseases. Funded by the NIH, her laboratory investigates age-specific vaccine responses and neonatal vaccine-induced trained immunity with a focus on Bacille Calmette-Guerin (BCG) vaccines. Ultimately, her research aims to understand the mechanisms of vaccine off-target effects and inform their optimal use in populations of different ages. With her clinical background and engagement in pre-clinical and human clinical vaccine studies, Dr. Angelidou’s long-term goal is to bridge translational investigation and clinical innovation to promote newborn health and improve childhood health outcomes.